United Therapeutics Corp (UTHR) Easily Beats Q3 Views; Revs Top $200M
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $545.96 +0.10%
Revenue Growth %: +1.5%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +1.5%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
United Therapeutics Corp (NASDAQ: UTHR) reported Q3 EPS of $1.65, $0.92 better than the analyst estimate of $0.73. Revenue for the quarter came in at $201.7 million versus the consensus estimate of $194.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
- Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
